Literature DB >> 22692086

Joint analysis of miRNA and mRNA expression data.

Ander Muniategui1, Jon Pey, Francisco J Planes, Angel Rubio.   

Abstract

miRNAs are small RNA molecules ('22 nt) that interact with their target mRNAs inhibiting translation or/and cleavaging the target mRNA. This interaction is guided by sequence complentarity and results in the reduction of mRNA and/or protein levels. miRNAs are involved in key biological processes and different diseases. Therefore, deciphering miRNA targets is crucial for diagnostics and therapeutics. However, miRNA regulatory mechanisms are complex and there is still no high-throughput and low-cost miRNA target screening technique. In recent years, several computational methods based on sequence complementarity of the miRNA and the mRNAs have been developed. However, the predicted interactions using these computational methods are inconsistent and the expected false positive rates are still large. Recently, it has been proposed to use the expression values of miRNAs and mRNAs (and/or proteins) to refine the results of sequence-based putative targets for a particular experiment. These methods have shown to be effective identifying the most prominent interactions from the databases of putative targets. Here, we review these methods that combine both expression and sequence-based putative targets to predict miRNA targets.

Keywords:  miRNA; miRNA mRNA expression; miRNA mRNA integration; miRNA target prediction

Mesh:

Substances:

Year:  2012        PMID: 22692086     DOI: 10.1093/bib/bbs028

Source DB:  PubMed          Journal:  Brief Bioinform        ISSN: 1467-5463            Impact factor:   11.622


  56 in total

1.  Integrated microRNA and mRNA responses to acute human left ventricular ischemia.

Authors:  Louis A Saddic; Tzuu-Wang Chang; Martin I Sigurdsson; Mahyar Heydarpour; Benjamin A Raby; Stanton K Shernan; Sary F Aranki; Simon C Body; Jochen D Muehlschlegel
Journal:  Physiol Genomics       Date:  2015-07-14       Impact factor: 3.107

Review 2.  Principles of miRNA-mRNA interactions: beyond sequence complementarity.

Authors:  Fabian Afonso-Grunz; Sören Müller
Journal:  Cell Mol Life Sci       Date:  2015-06-03       Impact factor: 9.261

3.  miRNA-target gene regulatory networks: A Bayesian integrative approach to biomarker selection with application to kidney cancer.

Authors:  Thierry Chekouo; Francesco C Stingo; James D Doecke; Kim-Anh Do
Journal:  Biometrics       Date:  2015-01-30       Impact factor: 2.571

4.  Statistical Methods in Integrative Genomics.

Authors:  Sylvia Richardson; George C Tseng; Wei Sun
Journal:  Annu Rev Stat Appl       Date:  2016-04-18       Impact factor: 5.810

Review 5.  Genetics of allergic diseases.

Authors:  Romina A Ortiz; Kathleen C Barnes
Journal:  Immunol Allergy Clin North Am       Date:  2014-11-21       Impact factor: 3.479

6.  Biclustering analysis of transcriptome big data identifies condition-specific microRNA targets.

Authors:  Sora Yoon; Hai C T Nguyen; Woobeen Jo; Jinhwan Kim; Sang-Mun Chi; Jiyoung Park; Seon-Young Kim; Dougu Nam
Journal:  Nucleic Acids Res       Date:  2019-05-21       Impact factor: 16.971

Review 7.  Integrating omics technologies to study pulmonary physiology and pathology at the systems level.

Authors:  Ravi Ramesh Pathak; Vrushank Davé
Journal:  Cell Physiol Biochem       Date:  2014-04-28

8.  Joint analysis of expression profiles from multiple cancers improves the identification of microRNA-gene interactions.

Authors:  Xiaowei Chen; Frank J Slack; Hongyu Zhao
Journal:  Bioinformatics       Date:  2013-06-14       Impact factor: 6.937

9.  MiR-145 improves macrophage-mediated inflammation through targeting Arf6.

Authors:  Rumei Li; Qiwei Shen; Nan Wu; Min He; Naijia Liu; Jinya Huang; Bin Lu; Qiyuan Yao; Yehong Yang; Renming Hu
Journal:  Endocrine       Date:  2018-01-31       Impact factor: 3.633

10.  Cell-type-specific miR-431 dysregulation in a motor neuron model of spinal muscular atrophy.

Authors:  Mary H Wertz; Kellen Winden; Pierre Neveu; Shi-Yan Ng; Ebru Ercan; Mustafa Sahin
Journal:  Hum Mol Genet       Date:  2016-03-22       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.